164 related articles for article (PubMed ID: 33021049)
1. Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
Balayan T; Begovac J; Skrzat-Klapaczyńska A; Aho I; Alexiev I; Bukovinova P; Salemovic D; Gokengin D; Harxhi A; Holban T; Jevtovic D; Kase K; Lakatos B; Latysheva I; Matulionyte R; Oprea C; Papadopoulos A; Rukhadze N; Sedlacek D; Tomazic J; Vassilenko A; Vasylyev M; Verhaz A; Yancheva N; Yurin O; Horban A; Kowalska JD;
HIV Med; 2021 Jan; 22(1):67-72. PubMed ID: 33021049
[TBL] [Abstract][Full Text] [Related]
2. HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
Kowalska JD; Bursa D; Gökengin D; Jilich D; Tomazic J; Vasylyev M; Bukovinowa P; Mulabdic V; Antonyak S; Horban A;
HIV Med; 2018 Oct; 19(9):629-633. PubMed ID: 29989332
[TBL] [Abstract][Full Text] [Related]
3. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
[TBL] [Abstract][Full Text] [Related]
4. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
Parikh UM; Mellors JW
Curr Opin HIV AIDS; 2016 Jan; 11(1):49-55. PubMed ID: 26633640
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofovir-emtricitabine or placebo in Botswana.
Kasonde M; Niska RW; Rose C; Henderson FL; Segolodi TM; Turner K; Smith DK; Thigpen MC; Paxton LA
PLoS One; 2014; 9(3):e90111. PubMed ID: 24625530
[TBL] [Abstract][Full Text] [Related]
6. Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France.
Noret M; Balavoine S; Pintado C; Siguier M; Brun A; Bauer R; Loze B; Leplatois A; Aslan A; Moudachirou K; Delaugerre C; Rozenbaum W; Molina JM
AIDS; 2018 Sep; 32(15):2161-2169. PubMed ID: 30212403
[TBL] [Abstract][Full Text] [Related]
7. Acute Trigeminal Neuralgia Associated with Initiation of Emtricitabine/Tenofovir for HIV Pre-Exposure Prophylaxis.
Van Slyke L; Scott M
J Int Assoc Provid AIDS Care; 2018; 17():2325958218760846. PubMed ID: 29534653
[TBL] [Abstract][Full Text] [Related]
8. Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-exposure Prophylaxis (PrEP) to Prevent HIV Infection.
van Epps P; Maier M; Lund B; Howren MB; Beck B; Beste L; Skolnik A; Vaughan-Sarrazin M; Ohl ME
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):272-278. PubMed ID: 29210835
[TBL] [Abstract][Full Text] [Related]
9. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.
Sullivan PS; Giler RM; Mouhanna F; Pembleton ES; Guest JL; Jones J; Castel AD; Yeung H; Kramer M; McCallister S; Siegler AJ
Ann Epidemiol; 2018 Dec; 28(12):833-840. PubMed ID: 30037634
[TBL] [Abstract][Full Text] [Related]
10. Evaluating statewide HIV preexposure prophylaxis implementation using All-Payer Claims Data.
Raifman J; Nocka K; Galárraga O; Wilson IB; Crowley C; Tao J; Napoleon S; Marak T; Chan PA
Ann Epidemiol; 2020 Apr; 44():1-7.e2. PubMed ID: 32279914
[TBL] [Abstract][Full Text] [Related]
11. The European preexposure prophylaxis revolution.
Cairns G; McCormack S; Molina JM
Curr Opin HIV AIDS; 2016 Jan; 11(1):74-9. PubMed ID: 26599164
[TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
[TBL] [Abstract][Full Text] [Related]
13. HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
Ascher SB; Scherzer R; Estrella MM; Shigenaga J; Spaulding KA; Glidden DV; Mehrotra ML; Defechereux P; Gandhi M; Grant RM; Shlipak MG; Jotwani V
AIDS; 2020 Apr; 34(5):699-706. PubMed ID: 31794523
[TBL] [Abstract][Full Text] [Related]
14. Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.
Koenig HC; Mounzer K; Daughtridge GW; Sloan CE; Lalley-Chareczko L; Moorthy GS; Conyngham SC; Zuppa AF; Montaner LJ; Tebas P
HIV Med; 2017 Jul; 18(6):412-418. PubMed ID: 28444867
[TBL] [Abstract][Full Text] [Related]
15. Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation.
Weis JF; Baeten JM; McCoy CO; Warth C; Donnell D; Thomas KK; Hendrix CW; Marzinke MA; Mugo N; Matsen FA; Celum C; Lehman DA;
AIDS; 2016 Jan; 30(1):31-5. PubMed ID: 26731753
[TBL] [Abstract][Full Text] [Related]
16. Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV.
Hodges-Mameletzis I; Dalal S; Msimanga-Radebe B; Rodolph M; Baggaley R
Sex Health; 2018 Nov; 15(6):489-500. PubMed ID: 30496718
[TBL] [Abstract][Full Text] [Related]
17. Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission.
Mandal S; Kang G; Prathipati PK; Zhou Y; Fan W; Li Q; Destache CJ
J Control Release; 2019 Jan; 294():216-225. PubMed ID: 30576746
[TBL] [Abstract][Full Text] [Related]
18. Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.
Mulligan K; Glidden DV; Anderson PL; Liu A; McMahan V; Gonzales P; Ramirez-Cardich ME; Namwongprom S; Chodacki P; de Mendonca LM; Wang F; Lama JR; Chariyalertsak S; Guanira JV; Buchbinder S; Bekker LG; Schechter M; Veloso VG; Grant RM;
Clin Infect Dis; 2015 Aug; 61(4):572-80. PubMed ID: 25908682
[TBL] [Abstract][Full Text] [Related]
19. PrEParing for Preexposure Prophylaxis.
Zappas MP; Foreman RM
J Dr Nurs Pract; 2020 Mar; 13(1):3-8. PubMed ID: 32701461
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Algorithms Used for PrEP Surveillance Using a Reference Population From New York City, July 2016-June 2018.
Furukawa NW; Smith DK; Gonzalez CJ; Huang YA; Hanna DB; Felsen UR; Zhu W; Arnsten JH; Patel VV
Public Health Rep; 2020; 135(2):202-210. PubMed ID: 32027559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
